- call +1-201-465-4211
- email sales@mrinsights.biz
Cell therapy (also called cellular therapy or cytotherapy) is therapy in which cellular material is injected into a patient; this generally means intact, living cells. For example, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy.
Scope of the Report:
This report studies the Cell Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cell Therapy market by product type and applications/end industries.
Cell therapy products, which are derived from stem cells, tissues, and organs grown in laboratories, are injected into patients. The growing number of clinical trials, government and private funding, and increasing number of partnerships between companies are driving the growth of the global cell therapy market. Cell therapy products that are available in the market are based on autologous and allogenic cells. The demand of cell therapy treatment is increasing. This is because cell therapy products can be used for personalized treatment.
The global Cell Therapy market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cell Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Dendreon
Mesoblast
Vericel
Novartis AG
GlaxoSmithKline plc
MEDIPOST
Osiris
PHARMICELL
NuVasive, Inc.
JCR Pharmaceuticals Co., Ltd
ANTEROGEN.CO.,LTD.
Cynata
CELLECTIS
BioNTech IMFS
EUFETS GmbH
Cognate
Pluristem
Grupo Praxis
Genzyme Corporation
Advanced Tissue
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Autologous
Allogeneic
Market Segment by Applications, can be divided into
Hospitals and clinics
ASCs
Regenerative medicine centers
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Cell Therapy Market Overview
1.1 Product Overview and Scope of Cell Therapy
1.2 Classification of Cell Therapy by Types
1.2.1 Global Cell Therapy Revenue Comparison by Types (2017-2023)
1.2.2 Global Cell Therapy Revenue Market Share by Types in 2017
1.2.3 Autologous
1.2.4 Allogeneic
1.3 Global Cell Therapy Market by Application
1.3.1 Global Cell Therapy Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals and clinics
1.3.3 ASCs
1.3.4 Regenerative medicine centers
1.4 Global Cell Therapy Market by Regions
1.4.1 Global Cell Therapy Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Cell Therapy Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cell Therapy Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cell Therapy Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Cell Therapy Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cell Therapy Status and Prospect (2013-2023)
1.5 Global Market Size of Cell Therapy (2013-2023)
2 Manufacturers Profiles
2.1 Dendreon
2.1.1 Business Overview
2.1.2 Cell Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Dendreon Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.2 Mesoblast
2.2.1 Business Overview
2.2.2 Cell Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Mesoblast Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.3 Vericel
2.3.1 Business Overview
2.3.2 Cell Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Vericel Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis AG
2.4.1 Business Overview
2.4.2 Cell Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis AG Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.5 GlaxoSmithKline plc
2.5.1 Business Overview
2.5.2 Cell Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GlaxoSmithKline plc Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.6 MEDIPOST
2.6.1 Business Overview
2.6.2 Cell Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 MEDIPOST Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.7 Osiris
2.7.1 Business Overview
2.7.2 Cell Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Osiris Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.8 PHARMICELL
2.8.1 Business Overview
2.8.2 Cell Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 PHARMICELL Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.9 NuVasive, Inc.
2.9.1 Business Overview
2.9.2 Cell Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 NuVasive, Inc. Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.10 JCR Pharmaceuticals Co., Ltd
2.10.1 Business Overview
2.10.2 Cell Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 JCR Pharmaceuticals Co., Ltd Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.11 ANTEROGEN.CO.,LTD.
2.11.1 Business Overview
2.11.2 Cell Therapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 ANTEROGEN.CO.,LTD. Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.12 Cynata
2.12.1 Business Overview
2.12.2 Cell Therapy Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Cynata Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.13 CELLECTIS
2.13.1 Business Overview
2.13.2 Cell Therapy Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 CELLECTIS Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.14 BioNTech IMFS
2.14.1 Business Overview
2.14.2 Cell Therapy Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 BioNTech IMFS Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.15 EUFETS GmbH
2.15.1 Business Overview
2.15.2 Cell Therapy Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 EUFETS GmbH Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.16 Cognate
2.16.1 Business Overview
2.16.2 Cell Therapy Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Cognate Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.17 Pluristem
2.17.1 Business Overview
2.17.2 Cell Therapy Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Pluristem Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.18 Grupo Praxis
2.18.1 Business Overview
2.18.2 Cell Therapy Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Grupo Praxis Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.19 Genzyme Corporation
2.19.1 Business Overview
2.19.2 Cell Therapy Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Genzyme Corporation Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.20 Advanced Tissue
2.20.1 Business Overview
2.20.2 Cell Therapy Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Advanced Tissue Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cell Therapy Market Competition, by Players
3.1 Global Cell Therapy Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Cell Therapy Players Market Share
3.2.2 Top 10 Cell Therapy Players Market Share
3.3 Market Competition Trend
4 Global Cell Therapy Market Size by Regions
4.1 Global Cell Therapy Revenue and Market Share by Regions
4.2 North America Cell Therapy Revenue and Growth Rate (2013-2018)
4.3 Europe Cell Therapy Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Cell Therapy Revenue and Growth Rate (2013-2018)
4.5 South America Cell Therapy Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Cell Therapy Revenue and Growth Rate (2013-2018)
5 North America Cell Therapy Revenue by Countries
5.1 North America Cell Therapy Revenue by Countries (2013-2018)
5.2 USA Cell Therapy Revenue and Growth Rate (2013-2018)
5.3 Canada Cell Therapy Revenue and Growth Rate (2013-2018)
5.4 Mexico Cell Therapy Revenue and Growth Rate (2013-2018)
6 Europe Cell Therapy Revenue by Countries
6.1 Europe Cell Therapy Revenue by Countries (2013-2018)
6.2 Germany Cell Therapy Revenue and Growth Rate (2013-2018)
6.3 UK Cell Therapy Revenue and Growth Rate (2013-2018)
6.4 France Cell Therapy Revenue and Growth Rate (2013-2018)
6.5 Russia Cell Therapy Revenue and Growth Rate (2013-2018)
6.6 Italy Cell Therapy Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Cell Therapy Revenue by Countries
7.1 Asia-Pacific Cell Therapy Revenue by Countries (2013-2018)
7.2 China Cell Therapy Revenue and Growth Rate (2013-2018)
7.3 Japan Cell Therapy Revenue and Growth Rate (2013-2018)
7.4 Korea Cell Therapy Revenue and Growth Rate (2013-2018)
7.5 India Cell Therapy Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Cell Therapy Revenue and Growth Rate (2013-2018)
8 South America Cell Therapy Revenue by Countries
8.1 South America Cell Therapy Revenue by Countries (2013-2018)
8.2 Brazil Cell Therapy Revenue and Growth Rate (2013-2018)
8.3 Argentina Cell Therapy Revenue and Growth Rate (2013-2018)
8.4 Colombia Cell Therapy Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Cell Therapy by Countries
9.1 Middle East and Africa Cell Therapy Revenue by Countries (2013-2018)
9.2 Saudi Arabia Cell Therapy Revenue and Growth Rate (2013-2018)
9.3 UAE Cell Therapy Revenue and Growth Rate (2013-2018)
9.4 Egypt Cell Therapy Revenue and Growth Rate (2013-2018)
9.5 Nigeria Cell Therapy Revenue and Growth Rate (2013-2018)
9.6 South Africa Cell Therapy Revenue and Growth Rate (2013-2018)
10 Global Cell Therapy Market Segment by Type
10.1 Global Cell Therapy Revenue and Market Share by Type (2013-2018)
10.2 Global Cell Therapy Market Forecast by Type (2018-2023)
10.3 Autologous Revenue Growth Rate (2013-2023)
10.4 Allogeneic Revenue Growth Rate (2013-2023)
11 Global Cell Therapy Market Segment by Application
11.1 Global Cell Therapy Revenue Market Share by Application (2013-2018)
11.2 Cell Therapy Market Forecast by Application (2018-2023)
11.3 Hospitals and clinics Revenue Growth (2013-2018)
11.4 ASCs Revenue Growth (2013-2018)
11.5 Regenerative medicine centers Revenue Growth (2013-2018)
12 Global Cell Therapy Market Size Forecast (2018-2023)
12.1 Global Cell Therapy Market Size Forecast (2018-2023)
12.2 Global Cell Therapy Market Forecast by Regions (2018-2023)
12.3 North America Cell Therapy Revenue Market Forecast (2018-2023)
12.4 Europe Cell Therapy Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Cell Therapy Revenue Market Forecast (2018-2023)
12.6 South America Cell Therapy Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Cell Therapy Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Cell Therapy Picture
Table Product Specifications of Cell Therapy
Table Global Cell Therapy and Revenue (Million USD) Market Split by Product Type
Figur
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
